THOMAS LLOYD to Aged, 80 and over
This is a "connection" page, showing publications THOMAS LLOYD has written about Aged, 80 and over.
Connection Strength
0.229
-
Loss of TDP-43 Splicing Repression Occurs in Myonuclei of Inclusion Body Myositis Patients. Ann Neurol. 2025 04; 97(4):629-641.
Score: 0.100
-
Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis. Ann Neurol. 2022 03; 91(3):317-328.
Score: 0.020
-
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607.
Score: 0.019
-
A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores. Neurology. 2020 03 03; 94(9):e884-e896.
Score: 0.018
-
Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A. Ann Neurol. 2019 03; 85(3):316-330.
Score: 0.017
-
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017 05 01; 56(5):787-794.
Score: 0.015
-
Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis. Ann Neurol. 2017 Feb; 81(2):227-239.
Score: 0.014
-
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA. J Neuromuscul Dis. 2016 03 03; 3(1):67-75.
Score: 0.014
-
Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Brain. 2015 Nov; 138(Pt 11):3180-92.
Score: 0.013